"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to KZR. [ FAQ on what and how to ask] For non-KZR questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Christopher J. Kirk Ph.D.
Headquarter: 4000 Shoreline Court, Suite 300, South San Francisco, CA, United States, 94080
Industry: Biotechnology, Employees: 55
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
My Watchlist
